1-(Piperazin-1-yl)-3-(thiophen-2-yl)prop-2-en-1-one

Catalog No.: 
ACDSCS273
CAS No.: 
58955-26-3
Molecular Formula: 
C11H14N2OS
Molecular Weight: 
222.31
1-(Piperazin-1-yl)-3-(thiophen-2-yl)prop-2-en-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$72.00InquiryInquiry
100mg95%$104.00InquiryInquiry
250mg95%$136.00InquiryInquiry
1g95%$349.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Piperazin-1-yl)-3-(thiophen-2-yl)prop-2-en-1-one
IUPAC Name(E)-1-(piperazin-1-yl)-3-(thiophen-2-yl)prop-2-en-1-one
MDL No.MFCD08444704
Molecular FormulaC11H14N2OS
Molecular Weight222.31
SMILESO=C(N1CCNCC1)/C=C/C2=CC=CS2
InChI KeySLQIYDKYEFNIBT-ONEGZZNKSA-N
Synonym1-(piperazin-1-yl)-3-(thiophen-2-yl)prop-2-en-1-one;2-Propen-1-one, 1-(1-piperazinyl)-3-(2-thienyl)-
CAS No.58955-26-3

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDSCS273 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDSCS273 route product structure diagram
    ACDSCS27358955-26-3
Inquiry

2. ACDSCS273 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSCS273 route product structure diagram
    ACDSCS27358955-26-3
Inquiry

3. ACDSCS273 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSCS273 route product structure diagram
    ACDSCS27358955-26-3
Inquiry

Comments (0)